Punuokang Biotechnology

China
Shuanghe, Hubei, China

Company profile

Punuokang Biotechnology company profile

Punuokang Bio is a veterinary pharmaceutical developer focusing on innovative treatments for pet metabolic diseases like heart disease, tumors, and kidney disease, which aligns with wider industry trends of advancing pet medicines for chronic conditions in companion animals.

Business identity

Operating status
Active
Company type
For Profit
Founded
2025-06-23

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$1.4M
Last funding
Angel / $1.4M / 2025-07-29
Last equity funding
Angel / $1.4M
Investors
1
Lead investors
1

Founders and investors

Lead investors

TriWise Capital

Investors

TriWise Capital